Teva Pharmaceutical Industries on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker’s alleged role in the US opioid ...

July 26 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the ...

Teva Pharmaceutical says it has reached an agreement in principle to settle thousands of lawsuits accusing it of fuelling the opioid crisis in the US for up to $4.25 billion, including already ...

The pharmaceutical company Teva has reached a $4.25 billion nationwide settlement, potentially resolving thousands of lawsuits over its role in the U.S. opioid crisis. The money will go primarily ...

The Israeli drugmaker Teva Pharmaceuticals has agreed to a proposed $4.25 billion deal to resolve thousands of lawsuits brought by states, other jurisdictions and, for the first time in a national ...

Teva Pharmaceutical Industries Ltd. said it reached a national settlement agreement worth up to $4.25 billion to resolve thousands of lawsuits over its alleged role in the opioid crisis.

The lawsuit claims that Teva “preyed upon the fundamental disconnect between the entities that pay for prescription medications (employers and insurers who pay claims incurred by health plan ...

Major drug company Teva will pay Baltimore City $80 million to settle claims that it helped fuel the city's opioid crisis. Baltimore sued "Big Pharma" - multiple major manufacturers and ...

Corcept Therapeutics Inc. shares CORT dropped 32% premarket on Tuesday after a federal court in New Jersey on Friday ruled against the drugmaker in its patent infringement lawsuit against Teva ...